Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma

Clinical Cancer Research

Volumn 9, Issue 10 I, 2003, Pages 3667-3673

  Li, Andrew J ^a   Baldwin, Rae Lynn ^a   Karlan, Beth Y ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; ALLELE; ANDROGEN ACTIVITY; ANDROGEN RECEPTOR GENE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SHORT ANDROGEN RECEPTOR ALLELE LENGTH; TRANSCRIPTION INITIATION;

ALLELES; BLOTTING, WESTERN; EPITHELIAL CELLS; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, ANDROGEN; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0141679420     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Risch, H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst. (Bethesda), 90: 1774-1786, 1998.
2. Helzsouer, K. J., Alberg, A. J., Gordon, G. B., Longcope, C., Bush, T. L., Hoffman, S. C., and Comstock, G. W. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA, 274: 1926-1930, 1995.
3. Silva, E. G., Tornos, C., Fritsche, H. A., el-Naggar, A., Gray, K., Ordonez, N. G., Luna, M., and Gershenson, D. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod. Pathol., 10: 879-883, 1997.
4. Chadha, S., Rao, B. R., Slotman, B. J., van Vroonhoven, C. C., and van der Kwast, T. H. An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Hum. Pathol., 24: 90-95, 1993.
5. Cardillo, M. R., Petrangeli, E., Aliotta, N., Salvatori, L., Ravenna, L., Chang, C., and Castagna, G. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J. Exp. Clin. Cancer Res., 17: 231-237, 1998.
6. Shaw, P. A., Rittenberg, P. V., and Brown, T. J. Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer. Gynecol. Oncol., 80: 132-138, 2001.
7. Evangelou, A., Jindal, S. K., Brown, T. J., and Letarte, M. Down-regulation of transforming growth factor β receptors by androgen in ovarian cancer cells. Cancer Res., 60: 929-935, 2000.
8. Chamberlain, N. L., Driver, E. D., and Miesfeld, R. L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res., 22: 3181-3186, 1994.
9. n-expanded neuronopathies. Hum. Mol. Genet., 4: 523-527, 1995.
10. Lyon, M. F. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature (Lond.), 190: 372-373, 1961.
11. Avner, P., and Heard, E. X.-chromosome inactivation: counting, choice and initiation. Nat. Rev. Genet., 2: 59-67, 2001.
12. Hsing, A. W., Gao, U. T., Wu, G., Wang, X., Deng, J., Chen, Y. L., Sesterhenn, I. A., Mostofi, F. K., Benichou, J., and Chang, C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res., 60: 5111-5116, 2000.
13. Levine, D. A., and Boyd, J. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. Cancer Res., 61: 908-911, 2001.
14. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Dahl, D., Brufsky, A., Talcott, J., Hennekens, C. H., and Kantoff, P. W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 3320-3323, 1997.
15. Yu, H., Bharaj, B., Vassilikos, E. J., Giai, M., and Diamandis, E. P. Shorter CAG repeat length in the androgen receptor is associated with more aggressive forms of breast cancer. Breast Cancer Res. Treat., 59: 153-161, 2000.
16. Rubin, S. C., Hoskins, W. J., Saigo, P. E., Chapman, D., Hakes, T. B., Markman, M., Reichman, B., Almadrones, L., and Lewis, J. L., Jr. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol. Oncol., 42: 137-141, 1991.
17. Omura, G. A., Brady, M. F., Homesley, H. D., Yordan, E., Major, F. J., Buchsbaum, H. J., and Park, R. C. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecol. Oncol. Group experience. J. Clin. Oncol., 9: 1138-1150, 1991.
18. Covens, A. L. A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol. Oncol., 78: 269-274, 2000.
19. Lau, K. M., Mok, S. C., and Ho, S. M. Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc. Natl. Acad. Sci. USA, 96: 5722-5727, 1999.
20. Spurdle, A. B., Webb, P. M., Chen, X., Martin, N. G., Giles, G. G., Hopper, J. L., and Chenevix-Trench, G. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer. Int. J. Cancer, 87: 637-643, 2000.
21. Karlan, B. Y., Jones, J., Greenwald, M., and Lagasse, L. D. Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro. Am. J. Obstet. Gynecol., 173: 97-104, 1995.
22. Baldwin, R. L., Tran, H., and Karlan, B. Y. Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis. Gynecol. Oncol., 74: 265-271, 1999.
23. Sambrook, J., and Russell, D. W. (eds.). Molecular Cloning: A Laboratory Manual, Ed. 3, pp. 6.1-6.64. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
24. Giovannucci, E., Platz, E. A., Stampfer, M. J., Chan, A., Krithivas, K., Kawachi, I., Willett, W. C., and Kantoff, P. W. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology, 53: 121-125, 1999.
25. Rebbeck, T. R., Kantoff, P. W., Krithivas, K., Neuhausen, S., Blackwood, M. A., Godwin, A. K., Daly, M. B., Narod, S. A., Garber, J. E., Lynch, H. T., Weber, B. L., and Brown, M. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am. J. Hum. Genet., 64: 1371-1377, 1999.
26. Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K., and Leung, P. C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocrine Rev., 22: 255-288, 2001.
27. Syed, V., Ulinski, G., Mok, S. C., Yiu, G. K., and Ho, S. M. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res., 61: 6768-6776, 2001.
28. Choi, K. C., Auersperg, N., and Leung, P. C. Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells. J. Clin. Endocrinol. Metab., 86: 5075-5078, 2001.
29. Jacobs, I. J., Kohler, M. F., Wiseman, R. W., Marks, J. R., Whitaker, R., Jerns, B. A., Humphrey, P., Berchuck A., Ponder B. A., and Bast, R. C. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterzygosity, p53 mutation, and X-chromosome inactivation. J. Natl. Cancer Inst. (Bethesda), 84: 1793-1798, 1992.
30. Tsao, S. W., Mok, C. H., Knapp, R. C., Oike, K., Muto, M. G., Welch, W. R., Goodman, H. M., Sheets, E. E., Berkowitz, R. S., and Lau, C. C. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol. Oncol., 48: 5-10, 1993.